G01N 33/6869
Interleukin
Official title: {Interleukin}
G01N33/6869 (Interleukin) appears on 707 US grants and 1,300 published applications in this corpus.
Search patents in G01N- Granted patents
- 707
- Published applications
- 1,300
- Assignees
- 668
- Inventors
- 2,558
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 9 | 0 |
| 1995 | 3 | 0 |
| 1996 | 11 | 0 |
| 1997 | 10 | 0 |
| 1998 | 21 | 0 |
| 1999 | 15 | 0 |
| 2000 | 7 | 0 |
| 2001 | 14 | 5 |
| 2002 | 7 | 16 |
| 2003 | 5 | 32 |
| 2004 | 6 | 27 |
| 2005 | 12 | 36 |
| 2006 | 14 | 31 |
| 2007 | 14 | 26 |
| 2008 | 14 | 40 |
| 2009 | 14 | 46 |
| 2010 | 26 | 46 |
| 2011 | 25 | 44 |
| 2012 | 22 | 40 |
| 2013 | 30 | 53 |
| 2014 | 26 | 78 |
| 2015 | 30 | 71 |
| 2016 | 27 | 69 |
| 2017 | 39 | 68 |
| 2018 | 40 | 70 |
| 2019 | 29 | 68 |
| 2020 | 44 | 73 |
| 2021 | 38 | 51 |
| 2022 | 33 | 69 |
| 2023 | 36 | 79 |
| 2024 | 18 | 56 |
| 2025 | 28 | 50 |
| 2026 | 27 | 56 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- Controlled release of antibodies to modulate cytokines8 Sep 2026US 12,729,237 B2Flow Pharma, Inc.
- Method for classifying an allergic patient as eligible to allergen immunotherapy8 Sep 2026US 12,730,114 B2Stallergenes Greer International AG
- Method of treating ichthyosis in a subject by administering an anti-interleukin 36 receptor (IL-36R) binding agent25 Aug 2026US 12,715,924 B2AnaptysBio, Inc.
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- Anti-il-13 long-acting nanobody sequence and applications thereof1 Oct 2026US 2026/0297175 A1Shanghai Novamab Biopharmaceuticals Co., Ltd.
- Anti il-11 antibody1 Oct 2026US 2026/0297176 A1
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
- Methods of treating alzheimer's disease17 Sep 2026US 2026/0274931 A1Klaritos, Inc.
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
Most cited
By later US patents
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- Antibodies to human programmed death receptor PD-1454US 8,354,509 B2MSD Oss B.V. · 2013
- Antibodies to human programmed death receptor PD-1151US 8,900,587 B2Merck Sharp & Dohme Corp. · 2014
- Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles113US 6,964,850 B2Source Precision Medicine, Inc. · 2005